Nageswaran Sivalingam
Dr Nageswaran Sivalingam, PhD is an expert in Biochemistry at SRM Institute of Science and Technology (India). Nageswaran Sivalingam has authored 23 publications, the most recent in 2026. SLR score: 92 (community average: 125). How the SLR is computed.
LeadR Profile
Biochemistry
Subspecialties: Oncology - Pharmacy - Toxicology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2009 - 2026
Number : 23
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| TGF-β2 promotes autophagy-mediated resistance to doxorubicin in metastatic colon cancer cells via HMGB1. PMID 42789212 — cells, genes, autophagy, microscopy, electron, scanning transmission, doxorubicin, neoplasms, colon, stem cells, cell line, colorectal neoplasms, hmgb1 protein, colonic neoplasms | Med Oncol | 2026 | 0 |
| Secretion of IL-6 and TGF-β2 by Colon Cancer Cells May Promote Resistance to Chemotherapy. PMID 41834939 — cells, neoplasms, adenocarcinoma, interleukin-6, colon, drug therapy, rectal neoplasms, therapeutics, mutation, colonic neoplasms, chemotherapy | Indian J Clin Biochem | 2024 | 0 |
| A recent decade update on combating doxorubicin-induced toxicities. PMID 40600983 — exercise, doxorubicin, neoplasms, cardiotoxicity, toxicology, therapeutics | Arch Toxicol | 2025 | 0 |
| Epigenetic modulation of doxorubicin resistance and strategies for enhancing chemotherapeutic sensitivity. PMID 39864895 — cells, doxorubicin, neoplasms, therapeutics | Int Rev Cell Mol Biol | 2024 | 0 |
| Mechanism of 5-fluorouracil induced resistance and role of piperine and curcumin as chemo-sensitizers in colon cancer. PMID 38878089 — cells, pharmaceutical preparations, colon, fluorouracil, pharmacology, curcumin, therapeutics, colorectal neoplasms, colonic neoplasms | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 5 |
LeadR Networks
Main global connection map